The Cancer Genetics Network (CGN) is a national network of centers specializing in the study of inherited predisposition to cancer. The CGN was formed in 1999, and receives funding from the National Cancer Institute. A Data Coordinating Center, 14 Clinical Centers, and an Informatics Group comprise the CGN. Together, these centers are working to make possible research that a single institution may not be able to accomplish because of insufficient numbers of participants, or the time needed to recruit them.

The CGN supports collaborative investigations on:

• the genetic basis of cancer susceptibility,
• mechanisms to integrate this new knowledge into medical practice, and
• means of addressing the associated psychosocial, ethical, legal, and public health issues.

While not currently enrolling new patients, the CGN has previously invited individuals to join who have a personal or family history of cancer, and who are willing to be contacted regarding participation in studies about inherited susceptibility to cancer. More than 26,000 individuals have enrolled in this unique program. Following enrollment, participants are contacted annually for updates to their medical history and personal and family cancer history, and this information is maintained in a central database.

The CGN has conducted 11 research studies since it began in 1999. Examples of CGN studies include screening studies in breast and ovarian cancer, and studies on the behavioral effects of cancer risk information. A complete list of the CGN research studies conducted to date can be found here.

The CGN welcomes opportunities to collaborate with researchers on important studies.